JPRN-UMIN000001032未知2 期
Phase II Study of Gemcitabine + S-1 in Elderly Patients With Non-Small Cell Lung Cancer - Phase II Study of Gemcitabine + S-1 in Elderly Patients With Non-Small Cell Lung Cancer
ational Hospital Organization Lung Cancer Study Group0 个研究点目标入组 35 人开始时间: 2008年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)No interstitial pneumonia or pulmonary fibrosis, as determined by chest x-ray 2)A history of severe allergic reactions to drugs 3) Patients with concurrent serious infections or complications are excluded 4) Clinically significant pleural/pericardial effusion which requires drainage before study entry. 5) Patients with an unstable or serious heart disease 6) Inadequately controlled diabetes mellitus 7) Symptomatic brain metastases 8) The presence of other concomitant or metachronous cancers 9)Any concomitant pathology that would, in the investigator`s opinion, contraindicate the use of the drugs in the protocol
研究者
相似试验
已完成
2 期
Phase II study of S-1 in patients with gemcitabine-refractory advanced biliary tract cancerPatients with gemcitabine-refractory advanced biliary tract cancerJPRN-UMIN000000919ational Cancer Center Hospital East Hepatobiliary and Pancreatic Oncology Division40
已完成
2 期
Phase II study of gemcitabine and S-1 combination therapy in advanced pancreatic cancer with malignant ascites.pancreatic cancer with ascitesJPRN-UMIN000003269ational Cancer Center Hospital East Hepatobiliary and Pancreatic Oncology Division36
已完成
2 期
Phase II study of gemcitabine/S-1 combination therapy in patients with non-resectable advanced biliary tract cancernon-resectable biliary tract cancer or recurrent biliary tract cancer post surgical treatmentJPRN-UMIN000000792Kyoto University Hospital25
已完成
2 期
Phase II/III study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemotherapy for resectable pancreatic cancer (Prep-02/JSAP-05)JPRN-UMIN000009634Study group of preoperative therapy for pancreatic cancer (PREP)/Japanese Study Group of Adjuvant Therapy for pancreatic Cancer (JSAP)364
招募中
1 期
Phase I/II study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemoradiationtherapy for borderline resectable pancreatic cancer (Prep-03/NS014-1)Borderline resectable pancreatic cancerJPRN-UMIN000014498Study group of preoperative therapy for pancreatic cancer (PREP)40